Armando Anido
-
Devon’s Zynerba Secured in $2 Million Deal by Harmony Biosciences
Devon-based Zynerba is set to be acquired by Harmony Biosciences Holdings in a $2 million deal, writes John George for the Philadelphia Business Journal. …
-
This Devon-Based Pharmaceutical Company Aims to Treat Autism with CBD
Zynerba Pharmaceuticals, a clinical-stage pharmaceutical company based in Devon, is testing a CBD gel to help treat autism, writes Queen Muse for Philadelphia magazine. The…
-
Devon-Based Developer of Synthetic Cannabinoid Therapies Narrows Its Focus
Devon’s Zynerba Pharmaceuticals, which develops synthetic cannabinoid therapies, is focusing on several rare and near-rare neurological and psychiatric disorders that have unmet medical needs, writes…
-
Devon’s Zynerba Pharmaceuticals Delays Human Testing for Marijuana Pain Patch
For Devon’s Zynerba Pharmaceuticals, the switch to a smaller patch for pain treatment using a synthetic cannabinoid has bumped back the company’s target date for…
-
Zynerba Extending Testing After Successful Trial of its Synthetic Cannabinoid Gel
It has been a good week for Zynerba Pharmaceuticals, as the Devon based company received very positive results from the first phase of testing on…
-
Update: Zynerba Pharmaceuticals Adds Board Members As Stock Rides Post-IPO Roller Coaster
Zynerba Pharmaceuticals is still experiencing a rollercoaster ride on the NASDAQ under the ticker ZYNE, since launching its more than fully subscribed Initial Public Offering…
-
Devon Medical Marijuana Startup Zynerba Pharmaceuticals Set To Go Public
A synthetic medical marijuana pioneer recently transplanted in Devon is experiencing an exciting high this week as it prepares to go public with 10 years…


















































